Published March 2018 | Version v1
Journal article

HDAC8 regulates neural differentiation through embryoid body formation in P19 cells

  • 1. Department of Pharmacy, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga 525-8577 (Japan)
  • 2. CREST, Japan Science and Technology Agency (JST), Kawaguchi, Saitama 332-0012 (Japan)
  • 3. Graduate School of Medical Sciences, Kyoto Prefectural University of Medicine, Sakyo-ku, Kyoto 606-0823 (Japan)
  • 4. Institute of Drug Discovery Science, Nagoya City University, Mizuho-ku, Nagoya 467-8603 (Japan)

Description

Highlights: • Selective HDAC8 inhibitor causes reduced embryoid body (EB) formation in P19 cells. • HDAC8-inhibited EBs show decreased neural differentiation activity. • HDAC8 inhibition leads to G2/M phase accumulation. • HDAC8 inhibition causes downregulation of cyclin A2 and cyclin B1 gene expression. • CRISPR-Cas9-mediated HDAC8 knockout cells show smaller EBs. Histone acetylation and deacetylation correlate with diverse biological phenomena through gene transcription. Histone deacetylases (HDACs) regulate deacetylation of histones and other proteins. However, as a member of the HDAC family, HDAC8 function during neurodevelopment is currently unknown. Therefore, we investigated HDAC8 function during neurodevelopment by examining embryoid body (EB) formation in P19 cells. HDAC8-selective inhibitor (NCC-149) (HDAC8i)-treated cells showed smaller EBs than non-treated cells, as well as reduced expression levels of the neuronal marker, NeuN. Additionally, HDAC8i treatment led to inhibition of cellular proliferation by G2/M phase accumulation and downregulated cyclin A2 and cyclin B1 gene expression. Furthermore, two independent HDAC8 knockout cell lines were established by CRISPR-Cas9, which resulted in smaller EBs, similar to HDAC8i-treated cells. These results suggest that HDAC8 regulates neural differentiation by exerting control of EB formation.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2018.02.195

Additional details

Identifiers

DOI
10.1016/j.bbrc.2018.02.195;
PII
S0006291X18304418;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
498
Journal Issue
1
Journal Page Range
p. 45-51
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54056599
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ACETYLATION; CELL CYCLE; CELL PROLIFERATION; GENES; HISTONES
Descriptors DEC
ACYLATION; CHEMICAL REACTIONS; ORGANIC COMPOUNDS; PROTEINS

Optional Information

Copyright
Copyright (c) 2018 Elsevier Inc. All rights reserved.